Elevated levels of serum macrophage migration inhibitory factor in patients with pulmonary tuberculosis

被引:32
作者
Yamada, G
Shijubo, N
Takagi-Takahashi, Y
Nishihira, J
Mizue, Y
Kikuchi, K
Abe, S
机构
[1] Sapporo Med Univ, Sch Med, Dept Internal Med 3, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
[2] Hokkaido Univ, Sch Med, Cent Res Inst, Sapporo, Hokkaido 060, Japan
[3] Sapporo Immunodiagnost Lab, Sapporo, Hokkaido, Japan
关键词
MIF; IFN-gamma; pulmonary tuberculosis;
D O I
10.1006/clim.2002.5255
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Macrophage migration inhibitory factor (MIF) was originally described as a T-cell-derived cytokine that inhibits the random migration of macrophages and promotes the delayed-type hypersensitivity reaction. MIF plays an important role in the regulation of the Th1/Th2 balance in inflammatory response. This study investigated serum levels of circulating MIF in patients with pulmonary tuberculosis. The levels of MIF in sera were measured by enzyme-linked immunosorbent assay in 34 patients with pulmonary tuberculosis (16 males and 18 females) and 30 healthy controls (15 males and 15 females). The mean levels of circulating MIF values were significantly higher in those with pulmonary tuberculosis (19.84 +/- 11.27 ng/ml; P < 0.0001) than in the healthy controls (4.38 +/- 1.34 ng/ml). Circulating MIF values significantly correlated with circulating interferon-gamma values (r = 0.537, P < 0.0001). Thus, MIF may play an important role in immune responses to human infection with Mycobacterium tuberculosis. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:123 / 127
页数:5
相关论文
共 29 条
[21]  
National Tuberculosis and Respiratory Disease Association, 1969, DIAGN STAND CLASS TU
[22]   Macrophage migration inhibitory factor (MIF): Its essential role in the immune system and cell growth [J].
Nishihira, J .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2000, 20 (09) :751-762
[23]  
Nishihira J, 1998, INT J MOL MED, V2, P17
[24]  
Podwinska J, 2000, FEMS IMMUNOL MED MIC, V28, P1, DOI 10.1111/j.1574-695X.2000.tb01451.x
[25]   Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection [J].
Satoskar, AR ;
Bozza, M ;
Sosa, MR ;
Lin, GS ;
David, JR .
INFECTION AND IMMUNITY, 2001, 69 (02) :906-911
[26]   The host immune response to tuberculosis [J].
Schluger, NW ;
Rom, WN .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (03) :679-691
[27]   IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis [J].
Taha, RA ;
Kotsimbos, TC ;
Song, YL ;
Menzies, D ;
Hamid, Q .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (03) :1135-1139
[28]   Increased levels of circulating interleukin-18 in patients with advanced turberculosis [J].
Yamada, G ;
Shijubo, N ;
Shigehara, K ;
Okamura, H ;
Kurimoto, M ;
Abe, S .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (06) :1786-1789
[29]  
Yamaguchi E, 2000, CLIN EXP ALLERGY, V30, P1244